Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Prostate Cancer Metastatic × cabazitaxel × Clear all

Phase

Status

Completed 4 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 8 Recurrence 2 Neoplasm Metastasis 2 Breast Neoplasms 2 Thrombocytosis 1 Prostate Cancer Metastatic 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Metastatic Breast Cancer With Intracranial Metastases 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hormone-Resistant Prostate Cancer 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Diarrhea 1 Colorectal Neoplasms 1

Interventions

enzalutamide 2 cabazitaxel 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02379390 2019-06-21

PRIMCAB

Sanofi

Phase 2 Terminated

8 enrolled 8 charts

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡